Navigation Links
Evolving Market Access in the APAC Region, a New Xtalks Life Sciences Webinar
Date:3/28/2013

Toronto, Canada (PRWEB) March 28, 2013

As the pharmaceutical industry in the West is being challenged with austerity and increasing pricing pressure, companies have started looking to diversify their portfolios through emerging markets. The countries within emerging markets are highly diverse and business models need to be locally tailored to ensure success.

The aim of this webinar is to cover market access related issues in the Asia Pacific region, including Japan and China, representing the world’s second and third largest pharmaceutical markets. South Korea and Taiwan, also major reimbursement markets as well as innovators in biologics and specialty products, will also be discussed.

This session will cover:

Ongoing healthcare reform in China and its implication on access

  • Top level regulatory requirement overview
  • Market access in China: What are Reimbursement Drug List and Essential Drug List and how are prices set?
  • Pricing trends
  • Healthcare reform bill and the impact on distribution channels
  • How to address the affordability issue?

Pricing trends and price premiums in Japan

  • Pricing and access principles
  • Reward for innovation
  • The utility of health economics

HTA in the APAC region:

  • The adaptation of Health Technology Assessment (HTA) in Japan and China
  • The impact of HTA on reimbursement, pricing and access in S Korea and Taiwan

For more information about this event or to register, visit: http://xtks.in/ZnKQUb.

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners t
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related biology technology :

1. NDIS Approval of Promega PowerPlex® Fusion System Assists Laboratories in Meeting Evolving Standards
2. MarketsandMarkets: Lung Cancer Drugs Market in G7 Countries Worth $13 Billion by 2020
3. Sequenom Announces Participation at the Lazard Capital Markets 8th Annual Healthcare Conference
4. Organovo to Present at Lazard Capital Markets 8th Annual Healthcare Conference
5. Pharmasset to Present at the Lazard Capital Markets Healthcare Conference
6. MarketsandMarkets: Global Prostate Cancer Therapeutics Market worth $6,457 Million by 2020
7. MarketsandMarkets: Leukemia Therapeutics Market Worth $11.3 Billion by 2020
8. ResearchMoz: Ophthalmic Devices Market to 2017 - Glaucoma and Cataract Surgery Devices, Minimally Invasive Procedures in Ophthalmic Surgery to Drive the Ophthalmic Surgery Market
9. GeneLink Marketing Efforts Poised to Show Results
10. Animal Biotechnology - Technologies, Markets and Companies
11. Gene Therapy - Technologies, Markets and Companies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2014)... , Nov. 24, 2014  Last week, Representatives ... Butterfield (D-NC) took a bold bipartisan step ... introducing the OPEN Act. Original co-sponsors of the ... The Act will incentivize drug makers and innovators ... diseases and pediatric cancers, which opens the door ...
(Date:11/24/2014)... SOUTH SAN FRANCISCO, Calif. , Nov. 24, 2014 /PRNewswire/ ... announced that Bonnie H. Anderson , president and chief ... the Piper Jaffray 26 th Annual Healthcare Conference on ... New York . The live audio ... website at http://investor.veracyte.com . Please connect to the website ...
(Date:11/24/2014)... 2014 2014 Deep Research Report ... a professional and in-depth research report on the ... like its definition, classification, application, and industry chain ... covers the international market analysis, including China’s domestic ... US, Europe, Asia, China, Japan etc. regions) industry ...
(Date:11/24/2014)... Senior Vice President, General Manager for Clinical ... acumen Elsevier , a world-leading provider ... congratulates Diane Bartoli , Senior Vice President and ... Solutions, for being recognized in the 13 th ... Profiles in Diversity Journal ® . ...
Breaking Biology Technology:OPEN Act Introduced to Repurpose Drugs for Rare Diseases 2Veracyte to Present at the Piper Jaffray 26th Annual Healthcare Conference 2Adipic Dihydrazide Industry 2019 Research Forecasts on Worldwide, China Regions Now Available at ReportsnReports.com 2Adipic Dihydrazide Industry 2019 Research Forecasts on Worldwide, China Regions Now Available at ReportsnReports.com 3Elsevier Clinical Solutions' Diane Bartoli Featured In Profiles in Diversity Journal's 13th Annual Women Worth Watching Issue 2Elsevier Clinical Solutions' Diane Bartoli Featured In Profiles in Diversity Journal's 13th Annual Women Worth Watching Issue 3
... Pharmaceuticals, Inc., a,biotechnology company focused on the development ... Drajeske as Director of Business,Development., Drajeske brings ... the life sciences industry. He formerly served as ... publicly traded biotechnology,company, from 2004 to 2006. While ...
... VELCADE(R) (bortezomib) for Injection sales surpassed $765 ... million in 2007 - - ... myeloma, with launch on track for first half ... MLNM ) today reported 2007 non-GAAP net,income of $86.9 million and GAAP net ...
... Application to be reviewed under European Accelerated ... Pharmion Corporation,(Nasdaq: PHRM ) today ... accepted for review the Company,s Marketing Authorization ... patients with,higher-risk myelodysplastic syndromes (MDS) and announced ...
Cached Biology Technology:Millennium Over-Delivers on 2007 Goals and Financial Guidance 2Millennium Over-Delivers on 2007 Goals and Financial Guidance 3Millennium Over-Delivers on 2007 Goals and Financial Guidance 4Millennium Over-Delivers on 2007 Goals and Financial Guidance 5Millennium Over-Delivers on 2007 Goals and Financial Guidance 6Millennium Over-Delivers on 2007 Goals and Financial Guidance 7Millennium Over-Delivers on 2007 Goals and Financial Guidance 8Millennium Over-Delivers on 2007 Goals and Financial Guidance 9Millennium Over-Delivers on 2007 Goals and Financial Guidance 10Millennium Over-Delivers on 2007 Goals and Financial Guidance 11Millennium Over-Delivers on 2007 Goals and Financial Guidance 12Millennium Over-Delivers on 2007 Goals and Financial Guidance 13Millennium Over-Delivers on 2007 Goals and Financial Guidance 14Millennium Over-Delivers on 2007 Goals and Financial Guidance 15Millennium Over-Delivers on 2007 Goals and Financial Guidance 16Millennium Over-Delivers on 2007 Goals and Financial Guidance 17Millennium Over-Delivers on 2007 Goals and Financial Guidance 18EMEA Accepts for Review Vidaza(R) Marketing Authorization Application for Higher-Risk Myelodysplastic Syndromes 2EMEA Accepts for Review Vidaza(R) Marketing Authorization Application for Higher-Risk Myelodysplastic Syndromes 3EMEA Accepts for Review Vidaza(R) Marketing Authorization Application for Higher-Risk Myelodysplastic Syndromes 4EMEA Accepts for Review Vidaza(R) Marketing Authorization Application for Higher-Risk Myelodysplastic Syndromes 5
(Date:11/21/2014)... Nov. 19, 2014  Earlier this year Donald ... College, and one of the most prolific inventors in ... are transmitted from Smartphones to third party agencies. Spector ... has one of the earliest known patents in this ... in the military, child care, elder care and hospital ...
(Date:11/18/2014)... 2014   News Highlights: ... develop The Partners Data Lake, an agile data ... Lake will allow researcher and clinicians to explore ... the lives of patients , The Partners ... across the Partners system, breaking down physical barriers ...
(Date:11/11/2014)... , Nov. 11, 2014  Forensicon, Inc., a ... firm, is pleased to announce the promotion of ... Director of Digital Forensics. In Schiff,s new role as ... the team of digital forensics examiners and provide leadership ... Photo - http://photos.prnewswire.com/prnh/20141110/157719 ...
Breaking Biology News(10 mins):Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 2Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 3Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 4Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 2Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 3Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 4Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 5Yaniv Schiff Promoted to Director of Digital Forensics at Forensicon, Inc. 2
... Columbia Engineering and Columbia University Medical Center announced ... bone structure in Chinese-American women to Caucasian women. ... Society,s annual meeting at Long Beach, CA, found ... strength than their Caucasian counterparts, as determined by ...
... kidney is made up of roughly 1 million working units ... the blood, recycle some substances to be reused and eliminate ... called the distal nephron, helps set blood pressure by controlling ... scientists at The University of Texas Health Science Center San ...
... Wild red deer on the Isle of Rum, which were ... the year, a study shows. Scientists believe the annual rutting ... warming spring and summer temperatures. The study shows that the ... on average compared with 30 years ago. The research ...
Cached Biology News:Columbia University uses technological innovation to study bone structure 2Columbia University uses technological innovation to study bone structure 3Warming climate means red deer rutting season arrives early 2
...
Mouse polyclonal antibody raised against a partial recombinant PREB. NCBI Entrez Gene ID = 10113...
Mouse monoclonal antibody raised against a partial recombinant CAPG. NCBI Entrez Gene ID = CAPG...
... used to test the crossreactivity of an ... are commonly used as blocking reagents or ... 19 different protein preparations on a nitrocellulose ... species specificity, QC of purified antibodies, selection ...
Biology Products: